Drug resistance and treatment failure in leishmaniasis: A 21st century challenge
Alicia Ponte‐Sucre(Central University of Venezuela), Barbara Papadopoulou(Centre d'Immunologie et des Maladies Infectieuses), Andrew W. Pountain(The University of Texas Health Science Center), Jean‐Claude Dujardin(University of Antwerp), Roy Mwenechanya(University of Zambia), Raquel García‐Hernández(Consejo Superior de Investigaciones Científicas), Francisco Gamarro(Instituto de Parasitología y Biomedicina "López - Neyra"), Michael P. Barrett(University of Glasgow), Rogelio López‐Vélez(Instituto de Salud Carlos III)
Cited by 990
Related Papers
Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort
|The Lancet HIV|2020|396
Human African trypanosomiasis: pharmacological re‐engagement with a neglected disease
|British Journal of Pharmacology|2007|323
Travel-associated infection presenting in Europe (2008–12): an analysis of EuroTravNet longitudinal, surveillance data, and evaluation of the effect of the pre-travel consultation
|The Lancet Infectious Diseases|2014|248
MetExplore: a web server to link metabolomic experiments and genome-scale metabolic networks
|Nucleic Acids Research|2010|186